Clinical and imaging findings in Parkinson disease associated with the A53E SNCA mutation
Open Access
- 1 December 2015
- journal article
- Published by Wolters Kluwer Health in Neurology Genetics
- Vol. 1 (4) , e27
Abstract
Objective: To describe the clinical features and brain imaging findings of autosomal dominant Parkinson disease (PD) associated with a recently reported mutation in SNCA. Methods: A Finnish family with PD in 3 successive generations, in accordance with an autosomal dominant inheritance pattern, was identified. We examined 2 available members of the family, the female proband and her daughter (both with early-onset PD), clinically and using dopamine transporter imaging ([123I]FP-CIT SPECT). A possible causative genetic defect was investigated by molecular genetic analyses. Results: A heterozygous c.158C>A (p.A53E) point mutation in SNCA was revealed in both patients. The patients presented with PD clinically characterized by severe bradykinesia but with very little tremor and early onset of levodopa-induced dyskinesia. No cognitive decline or dysautonomic features have emerged during more than 5 years of follow-up. Both patients presented with a severe striatal binding defect in dopamine transporter SPECT imaging. Conclusions: The results of this observational study add evidence to the suggestion that the p.A53E mutation in SNCA is indeed pathogenic and results in autosomal dominant PD. Bradykinesia and early onset of levodopa-induced dyskinesia are the characteristic clinical features associated with the A53E mutation, but the patients did not exhibit dementia or dysautonomia. The [123I]FP-CIT SPECT findings indicated a profound, symmetric dopaminergic defect, in contrast to those observed in patients with idiopathic PD.Keywords
This publication has 11 references indexed in Scilit:
- The Newly Discovered Parkinson’s Disease Associated Finnish Mutation (A53E) Attenuates α-Synuclein Aggregation and Membrane BindingBiochemistry, 2014
- A novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathologyNeurobiology of Aging, 2014
- G51D α‐synuclein mutation causes a novel Parkinsonian–pyramidal syndromeAnnals of Neurology, 2013
- A novel α-synuclein missense mutation in Parkinson diseaseNeurology, 2013
- Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's diseaseMovement Disorders, 2013
- α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy?Acta Neuropathologica, 2013
- Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10Human Mutation, 2008
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997